And Vertex announcing they want to buy into RNAi and gene therapy as well..the following from Fiercebio o/night.
Vertex ($VRTX) is ready to get its checkbook out to quell talk of it being a takeover target for Biogen ($BIIB) and Gilead ($GILD). The plan is to use the cash flow from recently approved cystic fibrosis drug Orkambi to strike pipeline-broadening deals, with gene therapy and RNA two fields in the company's sights.
RNAI rally underway, page-2
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)